$9.75
0.444.73%
In chiusura: -
$9.75
0.000.00%
After hour: 5:23 PM EDT
Comments
Loading...
Report sulle vendite allo scoperto
Il short interest su Zevra Therapeutics Inc (NASDAQ:ZVRA) è aumentato durante l'ultimo periodo di rilevazione, aumentando da 6.89M a 7.40M. Questo rappresenta il 13.26% delle azioni disponibili pubblicamente dell'azienda.
L'interesse allo scoperto in Zevra Therapeutics Corp (XNAS:ZVRA) è diminuito durante l'ultimo periodo di rendicontazione, passando da 280,30 milioni a 275,20 milioni. Ciò ha portato allo scoperto l'1,17% delle azioni pubbliche della società.
Sulla base del volume medio recente di 1.31M azioni scambiate al giorno, ci vorrebbero 5.65 giorno(i) per chiudere le posizioni di questo interesse a breve senza spingere fortemente al rialzo il titolo.
Vendite allo scoperto
7.40M
Vendite allo scoperto %
13.3%
Giorni di copertura
5.65
Get Alert | |||||||||
|---|---|---|---|---|---|---|---|---|---|
ZVRA | Zevra Therapeutics, Inc. Commo | 09/15/2025 | 09/24/2025 | 13.26% | 55,797,286 | 7,399,962 | 1,310,873 | 5.65 | |
ZVRA | Zevra Therapeutics, Inc. Commo | 08/29/2025 | 09/10/2025 | 12.36% | 55,797,286 | 6,894,109 | 1,221,402 | 5.64 | |
ZVRA | Zevra Therapeutics, Inc. Commo | 08/15/2025 | 08/26/2025 | 11.39% | 55,797,286 | 6,357,218 | 1,922,772 | 3.31 | |
ZVRA | Zevra Therapeutics, Inc. Commo | 07/31/2025 | 08/11/2025 | 8.54% | 54,341,836 | 4,641,411 | 1,033,909 | 4.49 | |
ZVRA | Zevra Therapeutics, Inc. Commo | 07/15/2025 | 07/24/2025 | 9.01% | 54,341,836 | 4,895,563 | 1,795,364 | 2.73 | |
ZVRA | Zevra Therapeutics, Inc. Commo | 06/30/2025 | 07/10/2025 | 9.19% | 54,341,836 | 4,993,420 | 528,823 | 9.44 | |
ZVRA | Zevra Therapeutics, Inc. Commo | 06/13/2025 | 06/25/2025 | 8.67% | 54,341,836 | 4,711,373 | 632,834 | 7.44 | |
ZVRA | Zevra Therapeutics, Inc. Commo | 05/30/2025 | 06/10/2025 | 10.43% | 54,341,836 | 5,669,892 | 586,837 | 9.66 | |
ZVRA | Zevra Therapeutics, Inc. Commo | 05/15/2025 | 05/27/2025 | 11.06% | 54,341,836 | 6,009,168 | 627,350 | 9.58 | |
ZVRA | Zevra Therapeutics, Inc. Commo | 04/30/2025 | 05/09/2025 | 10.31% | 54,341,558 | 5,600,724 | 376,590 | 14.87 | |
ZVRA | Zevra Therapeutics, Inc. Commo | 04/15/2025 | 04/25/2025 | 10.90% | 54,341,558 | 5,921,035 | 576,138 | 10.28 | |
ZVRA | Zevra Therapeutics, Inc. Commo | 03/31/2025 | 04/09/2025 | 10.95% | 53,928,836 | 5,907,650 | 459,287 | 12.86 | |
ZVRA | Zevra Therapeutics, Inc. Commo | 03/14/2025 | 03/25/2025 | 10.33% | 53,928,836 | 5,573,115 | 566,258 | 9.84 | |
ZVRA | Zevra Therapeutics, Inc. Commo | 02/28/2025 | 03/11/2025 | 10.55% | 53,188,899 | 5,612,280 | 318,062 | 17.65 | |
ZVRA | Zevra Therapeutics, Inc. Commo | 02/14/2025 | 02/26/2025 | 10.86% | 53,188,899 | 5,776,931 | 333,858 | 17.3 | |
ZVRA | Zevra Therapeutics, Inc. Commo | 01/31/2025 | 02/11/2025 | 10.38% | 53,188,899 | 5,522,234 | 431,425 | 12.8 | |
ZVRA | Zevra Therapeutics, Inc. Commo | 01/15/2025 | 01/27/2025 | 10.29% | 53,188,899 | 5,473,371 | 440,993 | 12.41 | |
ZVRA | Zevra Therapeutics, Inc. Commo | 12/31/2024 | 01/10/2025 | 8.78% | 53,188,899 | 4,668,012 | 587,124 | 7.95 | |
ZVRA | Zevra Therapeutics, Inc. Commo | 12/13/2024 | 12/24/2024 | 7.65% | 53,188,899 | 4,071,515 | 412,476 | 9.87 | |
ZVRA | Zevra Therapeutics, Inc. Commo | 11/29/2024 | 12/10/2024 | 8.09% | 53,188,899 | 4,305,541 | 539,157 | 7.99 | |
ZVRA | Zevra Therapeutics, Inc. Commo | 11/15/2024 | 11/26/2024 | 7.73% | 53,188,899 | 4,112,391 | 765,455 | 5.37 | |
ZVRA | Zevra Therapeutics, Inc. Commo | 10/31/2024 | 11/11/2024 | 7.51% | 52,430,756 | 3,937,545 | 456,695 | 8.62 | |
ZVRA | Zevra Therapeutics, Inc. Commo | 10/15/2024 | 10/24/2024 | 9.53% | 52,430,756 | 4,998,660 | 1,019,237 | 4.9 | |
ZVRA | Zevra Therapeutics, Inc. Commo | 09/30/2024 | 10/09/2024 | 9.04% | 52,430,756 | 4,739,350 | 1,711,257 | 2.77 | |
ZVRA | Zevra Therapeutics, Inc. Commo | 09/13/2024 | 09/24/2024 | 7.18% | 52,430,756 | 3,765,325 | 612,582 | 6.15 | |
ZVRA | Zevra Therapeutics, Inc. Commo | 08/30/2024 | 09/11/2024 | 7.31% | 52,430,756 | 3,832,701 | 571,817 | 6.7 | |
ZVRA | Zevra Therapeutics, Inc. Commo | 07/31/2024 | 08/09/2024 | 10.55% | 41,666,461 | 4,397,553 | 845,744 | 5.2 | |
ZVRA | Zevra Therapeutics, Inc. Commo | 07/15/2024 | 07/24/2024 | 7.61% | 41,666,461 | 3,169,614 | 508,819 | 6.23 | |
ZVRA | Zevra Therapeutics, Inc. Commo | 06/28/2024 | 07/10/2024 | 7.10% | 41,666,461 | 2,958,052 | 337,024 | 8.78 | |
ZVRA | Zevra Therapeutics, Inc. Commo | 06/14/2024 | 06/26/2024 | 6.63% | 41,666,461 | 2,764,428 | 163,060 | 16.95 | |
ZVRA | Zevra Therapeutics, Inc. Commo | 05/31/2024 | 06/11/2024 | 6.18% | 41,666,461 | 2,574,932 | 172,678 | 14.91 | |
ZVRA | Zevra Therapeutics, Inc. Commo | 05/15/2024 | 05/24/2024 | 6.43% | 41,666,461 | 2,677,362 | 222,829 | 12.02 | |
ZVRA | Zevra Therapeutics, Inc. Commo | 04/30/2024 | 05/09/2024 | 6.37% | 41,666,461 | 2,654,271 | 175,161 | 15.15 | |
ZVRA | Zevra Therapeutics, Inc. Commo | 04/15/2024 | 04/24/2024 | 5.69% | 41,663,461 | 2,372,040 | 286,533 | 8.28 | |
ZVRA | Zevra Therapeutics, Inc. Commo | 03/28/2024 | 04/09/2024 | 5.40% | 41,663,461 | 2,250,267 | 217,996 | 10.32 | |
ZVRA | Zevra Therapeutics, Inc. Commo | 03/15/2024 | 03/26/2024 | 5.48% | 38,945,938 | 2,132,431 | 304,040 | 7.01 | |
ZVRA | Zevra Therapeutics, Inc. Commo | 02/29/2024 | 03/11/2024 | 5.53% | 38,945,938 | 2,154,007 | 233,573 | 9.22 | |
ZVRA | Zevra Therapeutics, Inc. Commo | 01/31/2024 | 02/09/2024 | 5.46% | 38,945,938 | 2,127,067 | 179,837 | 11.83 | |
ZVRA | Zevra Therapeutics, Inc. Commo | 01/12/2024 | 01/24/2024 | 5.42% | 38,945,938 | 2,112,309 | 309,520 | 6.82 | |
ZVRA | Zevra Therapeutics, Inc. Commo | 12/29/2023 | 01/10/2024 | 5.34% | 38,945,938 | 2,080,533 | 441,189 | 4.72 | |
ZVRA | Zevra Therapeutics, Inc. Commo | 12/15/2023 | 12/27/2023 | 4.70% | 38,945,938 | 1,829,243 | 211,900 | 8.63 | |
ZVRA | Zevra Therapeutics, Inc. Commo | 11/30/2023 | 12/11/2023 | 5.18% | 38,945,938 | 2,017,927 | 193,196 | 10.44 | |
ZVRA | Zevra Therapeutics, Inc. Commo | 11/15/2023 | 11/27/2023 | 6.12% | 38,945,938 | 2,382,240 | 206,151 | 11.56 | |
ZVRA | Zevra Therapeutics, Inc. Commo | 10/31/2023 | 11/09/2023 | 6.33% | 35,979,112 | 2,276,939 | 119,861 | 19 | |
ZVRA | Zevra Therapeutics, Inc. Commo | 10/13/2023 | 10/24/2023 | 6.33% | 35,972,658 | 2,278,201 | 126,125 | 18.06 | |
ZVRA | Zevra Therapeutics, Inc. Commo | 09/29/2023 | 10/10/2023 | 6.54% | 35,972,658 | 2,352,432 | 136,505 | 17.23 |
In cerca di azioni più vendute allo scoperto?